Actively Recruiting
Adaptive Symptom Self-Management Immunotherapy Study
Led by University of Arizona · Updated on 2026-05-14
400
Participants Needed
3
Research Sites
207 weeks
Total Duration
On this page
Sponsors
U
University of Arizona
Lead Sponsor
N
National Cancer Institute (NCI)
Collaborating Sponsor
AI-Summary
What this Trial Is About
The use of immune checkpoint inhibitors (ICIs), alone or in combination with other cancer treatments is increasing dramatically with immune-related adverse events (irAEs) common (90%) during ICI treatment. Most irAEs are symptomatic and symptom self-management with timely reporting of moderate or severe symptoms to health care providers (HCPs) may reduce irAE severity by early recognition and management, resulting in fewer treatment interruptions and unscheduled health services.
CONDITIONS
Official Title
Adaptive Symptom Self-Management Immunotherapy Study
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age 18 or older
- Within 12 weeks after starting ICI treatment for cancer
- Cognitively oriented to person, place and time (determined by recruiter)
- Able to speak and understand English or Spanish
- Access to a telephone
- Severity score of 1 (mild) or higher on at least 1 of the 3 indicators of psychological distress from the PRO-CTCAE (i.e., the three items of anxious, discouraged, sad) library
You will not qualify if you...
- Currently receiving regular behavioral counseling
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 3 locations
1
Valleywise Health Medical Center
Phoenix, Arizona, United States, 85008
Active, Not Recruiting
2
University of Arizona Cancer Center
Tucson, Arizona, United States, 85724
Actively Recruiting
3
University of Michigan
Ann Arbor, Michigan, United States, 48109
Active, Not Recruiting
Research Team
M
Molly Hadeed
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
SEQUENTIAL
Primary Purpose
SUPPORTIVE_CARE
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here